Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Cash from Operations (2023 - 2025)

Historic Cash from Operations for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to -$21.3 million.

  • Metagenomi's Cash from Operations rose 2021.55% to -$21.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$91.6 million, marking a year-over-year increase of 1138.13%. This contributed to the annual value of -$109.1 million for FY2024, which is 1932.41% down from last year.
  • Metagenomi's Cash from Operations amounted to -$21.3 million in Q3 2025, which was up 2021.55% from -$21.3 million recorded in Q2 2025.
  • In the past 5 years, Metagenomi's Cash from Operations ranged from a high of -$20.6 million in Q4 2023 and a low of -$29.8 million during Q1 2024
  • Its 3-year average for Cash from Operations is -$24.2 million, with a median of -$23.7 million in 2023.
  • As far as peak fluctuations go, Metagenomi's Cash from Operations crashed by 4217.67% in 2024, and later soared by 2347.74% in 2025.
  • Over the past 3 years, Metagenomi's Cash from Operations (Quarter) stood at -$20.6 million in 2023, then decreased by 27.6% to -$26.3 million in 2024, then rose by 19.12% to -$21.3 million in 2025.
  • Its Cash from Operations was -$21.3 million in Q3 2025, compared to -$21.3 million in Q2 2025 and -$22.8 million in Q1 2025.